For example, tumor-derived APOE induced senescence of TRME and NEU cells, and that the removal of senescent cells neu by HDAC inhibitors could improve the therapeutic efficacy of prostate cancer treatment. This evidence concerns the gene HDAC9 and prostate carcinoma.